These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 30237016)
1. Review on the relevance of therapeutic drug monitoring of levetiracetam. Sourbron J; Chan H; Wammes-van der Heijden EA; Klarenbeek P; Wijnen BFM; de Haan GJ; van der Kuy H; Evers S; Majoie M Seizure; 2018 Nov; 62():131-135. PubMed ID: 30237016 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Levetiracetam in Select Populations. Jarvie D; Mahmoud SH J Pharm Pharm Sci; 2018; 21(1s):149s-176s. PubMed ID: 30096051 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma. Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy. Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring in pregnancy: Levetiracetam. Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747 [TBL] [Abstract][Full Text] [Related]
6. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy. Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA Seizure; 2020 May; 78():71-77. PubMed ID: 32213443 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy. Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra-performance liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy. Zhang M; Jin Y; Li W; He C; Di X; Duan Y; Chen L; Wang Z Biomed Chromatogr; 2024 Feb; 38(2):e5777. PubMed ID: 37990827 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring and the therapeutic reference range of levetiracetam for Chinese patients: Problems and issues. Shi M; Liu C; He L; Wu H; Wu Y Seizure; 2023 Jul; 109():26-33. PubMed ID: 37192596 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400 [TBL] [Abstract][Full Text] [Related]
11. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy. Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy. Kanemura H; Sano F; Ohyama T; Aihara M Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy. Li Y; Wang ML; Guo Y; Cao YF; Zhao MM; Zhao LM Br J Clin Pharmacol; 2023 Mar; 89(3):1152-1161. PubMed ID: 36260320 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy. Yamamoto Y; Ohta A; Usui N; Imai K; Kagawa Y; Takahashi Y Brain Dev; 2023 May; 45(5):285-292. PubMed ID: 36759254 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
16. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study. Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589 [TBL] [Abstract][Full Text] [Related]
17. Value of therapeutic drug level monitoring and unbound (free) levels. Chan K; Beran RG Seizure; 2008 Sep; 17(6):572-5. PubMed ID: 18262440 [TBL] [Abstract][Full Text] [Related]
18. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925 [TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848 [TBL] [Abstract][Full Text] [Related]
20. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy. Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]